Fortress Biotech Inc FBIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:47 AM EDT
0.834quote price arrow up+0.034 (+4.25%)
Volume
8,891
52 week range
0.77 - 3.81
Loading...
  • Open0.80
  • Day High0.8399
  • Day Low0.80
  • Prev Close0.80
  • 52 Week High3.81
  • 52 Week High Date09/29/21
  • 52 Week Low0.77
  • 52 Week Low Date06/01/22

Key Stats

  • Market Cap89.58M
  • Shares Out107.41M
  • 10 Day Average Volume1.18M
  • Dividend-
  • Dividend Yield-
  • Beta2.17
  • YTD % Change-66.48

KEY STATS

  • Open0.80
  • Day High0.8399
  • Day Low0.80
  • Prev Close0.80
  • 52 Week High3.81
  • 52 Week High Date09/29/21
  • 52 Week Low0.77
  • 52 Week Low Date06/01/22
  • Market Cap89.58M
  • Shares Out107.41M
  • 10 Day Average Volume1.18M
  • Dividend-
  • Dividend Yield-
  • Beta2.17
  • YTD % Change-66.48

RATIOS/PROFITABILITY

  • EPS (TTM)-0.86
  • P/E (TTM)-0.97
  • Fwd P/E (NTM)-1.46
  • EBITDA (TTM)-190.539M
  • ROE (TTM)-70.32%
  • Revenue (TTM)81.13M
  • Gross Margin (TTM)55.16%
  • Net Margin (TTM)-232.02%
  • Debt To Equity (MRQ)98.24%

EVENTS

  • Earnings Date08/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Fortress Biotech Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Fortress Biotech, Inc. (Fortress) is a biopharmaceutical company that acquires, develops and commercializes pharmaceutical and biotechnology products and product candidates. Fortress has nine marketed prescription pharmaceutical products and over 30 programs in development at Fortress, and at its partner companies. Its product candidates are used in oncology, rare diseases, and gene therapy. Its commercialized products include Qbrexza, a medicated cloth towelette for the...
Lindsay Rosenwald M.D.
Executive Chairman of the Board, President, Chief Executive Officer
Eric Rowinsky M.D.
Co-Vice Chairman of the Board
Michael Weiss J.D.
Executive Vice Chairman - Strategic Development, Director
Robyn Hunter
Chief Financial Officer, Treasurer, Corporate Secretary
Address
1111 KANE CONCOURSE, SUITE 301
Bay Harbor Islands, FL
33154
United States

Top Peers

SYMBOLLASTCHG%CHG
CTMX
CytomX Therapeutics Inc
1.87+0.03+1.63%
DTIL
Precision BioSciences Inc
1.56+0.03+1.90%
PSNL
Personalis Inc
3.43+0.03+0.91%
ATNX
Athenex Inc
0.4548+0.0218+5.03%
MGNX
MacroGenics Inc
3.13+0.08+2.62%